2009
DOI: 10.1016/j.ijpharm.2009.08.020
|View full text |Cite
|
Sign up to set email alerts
|

Ammonolysis-based microencapsulation technique using isopropyl formate as dispersed solvent

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 18 publications
(20 reference statements)
0
5
0
Order By: Relevance
“…Class 3 solvents with low toxic potential are favored in the pharmaceutical industry. Representative examples of Class 3 solvents used for the preparation of PLGA particles are acetone, ethyl acetate, butyl acetate, isopropyl formate, and glycofurol [197][198][199][200][201][202][203][204][205][206]. As shown in Table 3, acetone is the most predominantly used solvent for nanoprecipitation, but it exerts poor solvation power for high-molecular-weight PLGA polymers and certain hydrophobic drugs.…”
Section: Consideration Of Solvent Typementioning
confidence: 99%
“…Class 3 solvents with low toxic potential are favored in the pharmaceutical industry. Representative examples of Class 3 solvents used for the preparation of PLGA particles are acetone, ethyl acetate, butyl acetate, isopropyl formate, and glycofurol [197][198][199][200][201][202][203][204][205][206]. As shown in Table 3, acetone is the most predominantly used solvent for nanoprecipitation, but it exerts poor solvation power for high-molecular-weight PLGA polymers and certain hydrophobic drugs.…”
Section: Consideration Of Solvent Typementioning
confidence: 99%
“…When microspheres were prepared using ethyl acetate, the resultant microspheres displayed quite similar trends as described above ( Figure 7B). Interestingly, the maintenance of the physical status of progesterone is quite contrasting to the occurrence of its polymorphic transition into the b form during the ammonolysis-based microencapsulation process reported elsewhere (Lim and Sah, 2009). These contradictory results suggest that solvent type, manufacturing process, and the rate of solvent removal might closely interplay to decide the physical status of a drug during microencapsulation.…”
Section: Resultsmentioning
confidence: 63%
“…The solutions were subject to an HPLC analytical procedure, as described by Lim and Sah (2009). Briefly, one part of the tetrahydrofuran solution was diluted with five parts of methanol.…”
Section: Determination Of Drug Encapsulation Efficiencymentioning
confidence: 99%
See 1 more Smart Citation
“…This process can have significative relevance with acidic API, since an acidic aqueous phase will limit their diffusion and loss in the continuous phase. Other papers used isopropyl formate (Im and Sah 2009) or methyl chloroacetate (Kim et al 2007) as organic phase and their removal was carried out using ammonia solution that provoked solvent hydrolysis obtaining water-miscible formamide and isopropyl alcohol or chloroacetamide and methanol, respectively. As a result, the polymer precipitated encapsulating progesterone, used as a model API, with an encapsulation efficiency in the 64-97% range (Kim et al 2007;Im and Sah 2009).…”
Section: Catalytic Hydrolysis Solvent Removalmentioning
confidence: 99%